臺北醫學大學細胞治療與再生醫學研究中心

Medicine & Life Sciences

1. Taiwan 100%
2. Neoplasms 69%
3. Apoptosis 56%
4. Blood Platelets 55%
5. Stroke 54%
6. Lung 52%
7. Therapeutics 48%
8. Proteins 44%
9. Cohort Studies 39%
10. Mesenchymal Stem Cells 37%
11. Chronic Renal Insufficiency 36%
12. Lipopolysaccharides 36%
13. Population 36%
14. Hepatocellular Carcinoma 33%
15. Inflammation 33%
16. Gene Expression 33%
17. Reactive Oxygen Species 33%
18. Nanoparticles 32%
19. Genes 31%
20. Growth 31%
21. In Vitro Techniques 31%
22. Kidney 30%
23. Stem Cells 30%
24. Phosphorylation 30%
25. Hyperoxia 29%
26. Chronic Obstructive Pulmonary Disease 29%
27. Neoplasm Metastasis 29%
28. Confidence Intervals 28%
29. Wounds and Injuries 28%
30. Lung Neoplasms 27%
31. Renal Dialysis 27%
32. Breast Neoplasms 27%
33. Endothelial Cells 26%
34. Fibroblasts 26%
35. Macrophages 26%
36. Bone and Bones 25%
37. Up-Regulation 25%
38. Biomarkers 24%
39. Autophagy 24%
40. Down-Regulation 24%
41. Colorectal Neoplasms 23%
42. Meta-Analysis 23%
43. Cyclooxygenase 2 23%
44. Glycogen Synthase Kinase 3 22%
45. ErbB Receptors 21%
46. Connective Tissue Growth Factor 21%
47. Dengue Virus 21%
48. Epithelial Cells 21%
49. Epithelial-Mesenchymal Transition 21%
50. Messenger RNA 21%
51. Mortality 20%
52. Lung Injury 20%
53. Systematic Reviews 20%
54. Cell Proliferation 20%
55. Glioblastoma 19%
56. Traumatic Brain Injury 19%
57. Survival 19%
58. Mouth Neoplasms 19%
59. Nitric Oxide 19%
60. Endothelin-1 19%
61. Collagen 19%
62. Cell Movement 18%
63. Prostatic Neoplasms 18%
64. Dialysis 18%
65. Interleukin-8 18%
66. Colonic Neoplasms 18%
67. Cytokines 18%
68. Non-Small Cell Lung Carcinoma 18%
69. Oxidative Stress 18%
70. Dementia 18%
71. Fibrosis 17%
72. Nitric Oxide Synthase Type II 17%
73. Transforming Growth Factors 17%
74. Adenocarcinoma of Lung 17%
75. Extracellular Signal-Regulated MAP Kinases 17%
76. Small Interfering RNA 17%
77. glucose-regulated proteins 17%
78. MicroRNAs 16%
79. Glioma 16%
80. Cell Line 16%
81. Randomized Controlled Trials 16%
82. Cell Death 16%
83. Chitosan 16%
84. Antioxidants 16%
85. p38 Mitogen-Activated Protein Kinases 16%
86. Databases 16%
87. Serum 15%
88. Nicotine 15%
89. Platelet-Rich Plasma 15%
90. Interleukin-1 15%
91. Human Umbilical Vein Endothelial Cells 15%
92. Dental Pulp 15%
93. Pharmaceutical Preparations 15%
94. Smooth Muscle Myocytes 15%
95. Odds Ratio 15%
96. Safety 15%
97. Squamous Cell Carcinoma 14%
98. Matrix Metalloproteinases 14%
99. Matrix Metalloproteinase 9 14%

Chemical Compounds

1. Protein 58%
2. Reactive Oxygen Metabolite 23%
3. Plasma 22%
4. Growth Factor 21%
5. Collagen 21%
6. Marker 20%
7. Nanoparticle 18%
8. Biological Marker 17%
9. Drug 17%
10. Apoptotic 17%
11. Chitosan 16%
12. Cell Death 15%
13. Antioxidant Agent 15%
14. Air Pollution 14%
15. Fucoidan 14%
16. Application 14%
17. Lipopolysaccharide 13%
18. Oxidative Stress 13%
19. Safety 11%
20. Neuroprotective 11%
21. Nitric Oxide 11%
22. Cell Viability 10%
23. Hydrogel 10%
24. Resistance 10%
25. Implant 9%
26. Osteogenic 9%
27. Histone 9%
28. Reduction 9%
29. Anticoagulant Agent 9%
30. Antiinflammatory 9%
31. MicroRNA 9%
32. Protective 9%
33. Disorder 9%
34. Chemoattractant 9%
35. Hyaluronic Acid 9%
36. Dose 8%
37. Glycogen 8%
38. Weight 8%
39. Insulin Derivative 8%
40. Time 8%
41. Gelatin 8%
42. Surface 7%
43. Small Interfering RNA 7%
44. Acid 7%
45. Mutation 7%
46. Retinal 7%
47. Metabolic 7%
48. Composite Material 7%
49. Blood Pressure 7%
50. Endothelin-1 6%
51. Ocular 6%
52. Silencing RNA 6%
53. Phosphotransferase Inhibitor 6%
54. Volume 6%
55. Flow 6%
56. Temozolomide 6%
57. Andrographolide 6%
58. Genetic Polymorphism 6%
59. Angiotensin II 6%
60. Dioxygen 6%
61. Phosphoinositide 5%
62. Western Blotting 5%
63. Ceramide 5%
64. Pharmacological Metabolism 5%
65. Biomaterial 5%
66. Calcium(0) 5%
67. Doxorubicin 5%
68. Antigen 5%
69. Low-Density Lipoprotein 5%
70. Tetramethylpyrazine 5%
71. Thrombin 5%
72. Peptide 5%
73. Gallate 5%
74. Permeability 5%
75. Microarrays 5%
76. Chain Reaction 5%
77. Fibrous Crystal 5%
78. pH Value 5%
79. Ribonucleotide 5%